In a uremic mouse model of chronic kidney disease, a vascular smooth muscle cell phenotype change, reflected by the loss of SMA and other smooth muscle markers and the upregulation of MMP-2, preceded cell loss and arterial medial calcification (48, 49). This evidence concerns the gene MMP2 and chronic kidney disease.